Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
Aeglea BioTherapeutics reports 2018 executive compensation
By ExecPay News
Published: April 22, 2019
Aeglea BioTherapeutics reported fiscal year 2018 executive compensation information on April 22, 2019.
In 2018, three executives at Aeglea BioTherapeutics received on average a compensation package of $1.8M, a 63% increase compared to previous year.
Average pay of disclosed executives at Aeglea BioTherapeutics
Anthony G. Quinn, Chief Executive Officer, received $3.8M in total, which increased by 274% compared to 2017. 76% of Quinn's compensation, or $2.9M, was in stock awards. Quinn also received $304K in bonus, $507K in salary, as well as $112K in other compensation.
Charles N. York II, Chief Financial Officer, received a compensation package of $961K, which decreased by 15% compared to previous year. 44% of the compensation package, or $425K, was in stock awards.
James Wooldridge, Chief Medical Officer, earned $744K in 2018, a 20% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2019.